"The average cost for a company to get Premarket Approval from the FDA is about $130 AUD (depending on the exchange rate)"
synaphai in the last interview with Proactive Investors the CEO stated that, should the company decide to take it all the way through, most of the big studies will be reimbursed and paid for by the hospitals where we are treating the patients. Whilst he didn't say it I formed the opinion that he is not expecting to have to raise a lot more capital to get the trials under way. He also mentioned the possibility of "breakthrough status" because of the unique properties of DurAvr which , if granted, should get things moving a little faster.
"The average cost for a company to get Premarket Approval from...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 156 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.00 | 6045 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |